|
Cost effectiveness of cardiac resynchronization therapy in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) trial |
Feldman A M, De Lissovoy G, Bristow M R, Saxon L A, De Marco T, Kass D A, Boehmer J, Singh S, Whellan D J, Carson P, Boscoe A, Baker T M, Gunderman M R |
|
|
Record Status This is an economic evaluation that meets the criteria for inclusion on NHS EED. Bibliographic details Feldman A M, De Lissovoy G, Bristow M R, Saxon L A, De Marco T, Kass D A, Boehmer J, Singh S, Whellan D J, Carson P, Boscoe A, Baker T M, Gunderman M R. Cost effectiveness of cardiac resynchronization therapy in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) trial. Journal of the American College of Cardiology 2005; 46(12): 2311-2321 Indexing Status Subject indexing assigned by NLM MeSH Cardiac Output, Low /drug therapy /physiopathology /therapy; Cardiac Pacing, Artificial /economics; Cardiotonic Agents /therapeutic use; Cost-Benefit Analysis; Electric Countershock /economics; Health Care Costs; Hospital Costs; Humans; Models, Economic; Quality-Adjusted Life Years; Randomized Controlled Trials as Topic; Severity of Illness Index; Survival Analysis AccessionNumber 22006000070 Date bibliographic record published 19/01/2006 |
|
|
|